Literature DB >> 9813374

Interactions of surfactant protein D with pathogens, allergens and phagocytes.

K B Reid1.   

Abstract

Surfactant protein D (SP-D) is considered to play an important role in innate immunity in the lungs by binding, via its multiple C-type lectin domains, to carbohydrate structures present on a range of viruses, bacteria, yeasts and fungi. The resulting agglutination of the target pathogens provides host defence which can be further enhanced by killing and clearance mechanisms mediated by phagocytic cells which carry receptors for SP-D. Recent findings suggest that SP-D, and the structurally related lung surfactant protein A (SP-A), may also modulate allergic reactions by binding certain glycosylated allergens. The finding of SP-D at a variety of other sites besides the lungs, such as the gastric mucosae, is suggestive that it may play a general protective role in several secretions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813374     DOI: 10.1016/s0925-4439(98)00074-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia.

Authors:  M J Allen; R Harbeck; B Smith; D R Voelker; R J Mason
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice.

Authors:  S E Wert; M Yoshida; A M LeVine; M Ikegami; T Jones; G F Ross; J H Fisher; T R Korfhagen; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

3.  Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis.

Authors:  T Madan; U Kishore; M Singh; P Strong; E M Hussain; K B Reid; P U Sarma
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus.

Authors:  M J Allen; D R Voelker; R J Mason
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

5.  Intranasal delivery of a truncated recombinant human SP-D is effective at down-regulating allergic hypersensitivity in mice sensitized to allergens of Aspergillus fumigatus.

Authors:  P Strong; K B M Reid; H Clark
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

6.  Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae.

Authors:  I Ofek; A Mesika; M Kalina; Y Keisari; R Podschun; H Sahly; D Chang; D McGregor; E Crouch
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens.

Authors:  T Madan; U Kishore; M Singh; P Strong; H Clark; E M Hussain; K B Reid; P U Sarma
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

8.  Expression of surfactant protein D in the human gastric mucosa and during Helicobacter pylori infection.

Authors:  Emma Murray; Wafa Khamri; Marjorie M Walker; Paul Eggleton; Anthony P Moran; John A Ferris; Susanne Knapp; Q Najma Karim; Mulegata Worku; Peter Strong; Kenneth B M Reid; Mark R Thursz
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

Review 9.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

10.  Structural characterisation of ligand-binding determinants in human lung surfactant protein D: influence of Asp325.

Authors:  A K Shrive; C Martin; I Burns; J M Paterson; J D Martin; J P Townsend; P Waters; H W Clark; U Kishore; K B M Reid; T J Greenhough
Journal:  J Mol Biol       Date:  2009-09-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.